UNICA IRIS Institutional Research Information System

MASSA, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 146.532
NA - Nord America 12.792
AS - Asia 5.610
SA - Sud America 814
Continente sconosciuto - Info sul continente non disponibili 374
AF - Africa 150
OC - Oceania 15
AN - Antartide 1
Totale 166.288
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 141.450
US - Stati Uniti d'America 12.564
SG - Singapore 2.088
CN - Cina 2.076
NL - Olanda 1.905
UA - Ucraina 966
SE - Svezia 652
BR - Brasile 611
VN - Vietnam 500
FI - Finlandia 394
DE - Germania 329
GB - Regno Unito 321
FR - Francia 263
HK - Hong Kong 184
KR - Corea 145
CA - Canada 125
IN - India 117
BD - Bangladesh 87
AR - Argentina 73
MX - Messico 54
ZA - Sudafrica 52
TR - Turchia 51
IQ - Iraq 49
AT - Austria 41
JP - Giappone 37
PK - Pakistan 35
RU - Federazione Russa 35
PH - Filippine 33
IR - Iran 30
CO - Colombia 27
ES - Italia 27
ID - Indonesia 27
EC - Ecuador 26
PL - Polonia 25
BE - Belgio 23
SA - Arabia Saudita 23
CL - Cile 21
IE - Irlanda 19
KE - Kenya 18
UZ - Uzbekistan 18
VE - Venezuela 18
MA - Marocco 17
CZ - Repubblica Ceca 15
JM - Giamaica 15
PY - Paraguay 15
AE - Emirati Arabi Uniti 13
TN - Tunisia 13
AU - Australia 12
MY - Malesia 11
TW - Taiwan 11
EG - Egitto 10
PE - Perù 10
CR - Costa Rica 9
NP - Nepal 9
BO - Bolivia 8
ET - Etiopia 8
JO - Giordania 8
RO - Romania 8
CH - Svizzera 7
EU - Europa 7
KZ - Kazakistan 7
LT - Lituania 7
NG - Nigeria 7
OM - Oman 6
AZ - Azerbaigian 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
LV - Lettonia 5
AL - Albania 4
AM - Armenia 4
GR - Grecia 4
IL - Israele 4
LB - Libano 4
PT - Portogallo 4
TH - Thailandia 4
UY - Uruguay 4
BB - Barbados 3
BG - Bulgaria 3
BH - Bahrain 3
CG - Congo 3
HN - Honduras 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
MK - Macedonia 3
NI - Nicaragua 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
UG - Uganda 3
AO - Angola 2
BS - Bahamas 2
CI - Costa d'Avorio 2
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
HU - Ungheria 2
Totale 165.889
Salva come PNG Salva come JPEG
Città #
Cagliari 136.373
Uta 4.291
Amsterdam 1.880
Fairfield 1.171
Ashburn 1.050
Singapore 1.043
Woodbridge 1.023
Houston 834
Chandler 678
San Jose 666
Dallas 644
Boardman 567
Jacksonville 558
Seattle 501
Wilmington 483
Ann Arbor 480
Nyköping 466
Cambridge 413
Beijing 360
Dearborn 258
Council Bluffs 232
Helsinki 226
Los Angeles 204
Ho Chi Minh City 189
Nanjing 174
Santa Clara 174
Hong Kong 163
Hefei 158
Boston 149
New York 146
Lauterbourg 145
The Dalles 139
Seoul 132
Shanghai 118
Buffalo 105
Guangzhou 96
Hanoi 92
San Diego 92
Milan 85
Munich 58
Nanchang 57
Shenyang 49
São Paulo 47
Toronto 47
Rome 46
Hangzhou 45
London 44
Changsha 43
Chicago 42
Hebei 42
Redondo Beach 40
Tianjin 40
Redwood City 36
Jiaxing 34
Frankfurt am Main 33
Orem 33
Jinan 32
Verona 32
Nuremberg 29
Tokyo 29
Norwalk 28
Phoenix 28
Rio de Janeiro 28
Orange 26
Da Nang 24
Atlanta 23
Columbus 23
Pune 22
Warsaw 22
Brussels 21
Sassari 21
Baghdad 20
Brooklyn 20
Johannesburg 20
Auburn Hills 19
Chennai 19
Vienna 19
Zhengzhou 19
Belo Horizonte 18
Dublin 18
Haiphong 18
Kunming 18
Montreal 18
Mountain View 18
Turku 18
San Francisco 17
Denver 16
Manchester 16
Mexico City 16
Naples 16
Tashkent 16
Wuhan 16
Dhaka 15
Shenzhen 14
Stockholm 14
Ankara 13
Biên Hòa 13
Istanbul 13
San Mateo 13
Dong Ket 12
Totale 158.164
Salva come PNG Salva come JPEG
Nome #
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.888
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.988
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.957
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.834
Molecular-biology-driven treatment for metastatic colorectal cancer 2.777
Sense of coherence and physical health-related quality of life in Italian chronic patients: The mediating role of the mental component 2.736
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.644
Alcohol consumption is a modifiable risk factor for breast cancer: Are women aware of this relationship? 2.617
CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients 2.583
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.461
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.340
VITAMIN C SUPPLEMENTATION IN CANCER CACHEXIA AND RELATED-OXIDATIVE STRESS 2.260
Health related quality of life in patients with onco-hematological diseases 2.243
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.194
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.892
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial 1.847
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.795
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial 1.780
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 1.752
The nutritional risk in oncology: a study of 1,453 cancer outpatients 1.734
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.726
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.720
The Quality of Life of People with Solid Cancer is Less Worse than Other Diseases with better Prognosis, Except in the Presence of Depression 1.696
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.693
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.675
Active elderly and health—can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial 1.656
Position paper of the Italian Association of Medical Oncology on early palliative care in oncology practice (Simultaneous Care) 1.654
Immunotherapy and Cancer: The Multi-Omics Perspective 1.625
Weight loss in cancer patients: a plea for a better awareness of the issue 1.598
Case-control Phase ii clinical trial to assess efficacy and safety, of the same antineoplastic treatment(s) in elderly "fit" compared to adult patients with cancer at different sites 1.556
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.516
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause 1.512
null 1.489
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.484
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia = Therapeutic decisions and treatment with sorafenib in hepatocellular carcinoma: Final analysis of GIDEON study in Italy 1.483
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.329
null 1.306
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.287
Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens 1.222
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.200
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.183
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.154
Moderate exercise improves cognitive function in healthy elderly people: results of a randomized controlled trial 1.146
Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma 1.089
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 1.072
PAX8 Positivity, Abnormal p53 Expression, and p16 Negativity in a Primary Endometrial Squamous Cell Carcinoma: A Case Report and Review of the Literature 1.039
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study 1.023
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 1.004
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 996
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer 972
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 966
An attempt to correlate a "Multidimensional Geriatric Assessment" (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study 953
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 946
null 944
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial 920
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer 894
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress 849
ALCOL E TUMORE ALLA MAMMELLA 820
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 819
Association of serum IL-6 levels with comprehensive geriatric assessment variables in a population of elderly cancer patients 803
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 794
A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress 789
A PHASE II STUDY WITH ANTIOXIDANTS, BOTH IN THE DIET AND SUPPLEMENTED, PHARMACO-NUTRITIONAL SUPPORT,PROGESTAGEN AND ANTI-COX-2 SHOWING EFFICACY AND SAFETY IN PATIENTS WITH CANCER-RELATED ANOREXIA-CACHEXIA AND OXIDATIVE STRESS 788
Prevention of nausea and vomiting (N&V) in cancer patients receiving high-dose cisplatin. Assessment of the potential antiemetic activity of transdermal fentanyl (TTS-F) compared to standard antiemetic treatment in acute and delayed N&V: first clinical report 787
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 785
Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment 783
Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment 773
null 768
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 768
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 760
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 757
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 743
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 732
Early epirubicin (EPI)-induced myocardial dysfunction revealed by serial tissue doppler imaging (TDI): Correlation with inflammatory and oxidative stress markers 728
Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy 724
null 709
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2 705
Risk factors for sentinel lymph node involvement in patients with apparent early-stage endometrial cancer: a retrospective single-center study 694
null 694
null 688
HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review 686
null 681
Low adherence to therapy and co-morbid depressive episodes are independent determinants of early death in people with cancer 659
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 638
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity 637
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 632
p16 Block Type Overexpression, p53 Wild Type Reactivity, and Cervical Involvement do not Always Exclude the Diagnosis of Primary Endometrial Squamous Cell Carcinoma (PESCC) 627
Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites 626
Adherence to treatment in patients with solid and hematological cancers. Could spiritual and psychological support facilitate optimal adherence? 618
Managing cancer-related anorexia/cachexia 618
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 617
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 612
Cancer-related cachexia and oxidative stress: beyond current therapeutic options 611
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 607
Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer 601
Serum levels of leptin and proinflammatory cytokines in patients with advanced stage cancer at different sites 596
The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression 595
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 593
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites 590
null 572
Totale 126.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 242.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 242.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.029 0 561 269 475 659 504 320 348 583 492 814 1.004
2022/202312.087 956 1.396 1.196 1.047 1.060 1.211 577 1.429 832 772 1.019 592
2023/202415.869 1.357 542 511 1.008 1.574 3.191 1.579 1.023 781 1.356 1.512 1.435
2024/202533.508 7.200 9.237 4.138 3.944 2.037 3.756 1.424 182 446 310 384 450
2025/202612.515 592 558 1.260 878 773 699 1.857 650 2.687 1.484 733 344
2026/2027884 114 770 0 0 0 0 0 0 0 0 0 0
Totale 166.288